[go: up one dir, main page]

GB201621446D0 - IL-11 antibodies - Google Patents

IL-11 antibodies

Info

Publication number
GB201621446D0
GB201621446D0 GBGB1621446.2A GB201621446A GB201621446D0 GB 201621446 D0 GB201621446 D0 GB 201621446D0 GB 201621446 A GB201621446 A GB 201621446A GB 201621446 D0 GB201621446 D0 GB 201621446D0
Authority
GB
United Kingdom
Prior art keywords
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1621446.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Singapore Health Services Pte Ltd And Nat Univ Of Singapore
Original Assignee
Singapore Health Services Pte Ltd And Nat Univ Of Singapore
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Singapore Health Services Pte Ltd And Nat Univ Of Singapore filed Critical Singapore Health Services Pte Ltd And Nat Univ Of Singapore
Priority to GBGB1621446.2A priority Critical patent/GB201621446D0/en
Publication of GB201621446D0 publication Critical patent/GB201621446D0/en
Priority to CA3045871A priority patent/CA3045871A1/en
Priority to BR112019012342A priority patent/BR112019012342A2/en
Priority to CN201780078160.XA priority patent/CN110382531B/en
Priority to JP2019531960A priority patent/JP7181870B2/en
Priority to EP17823089.2A priority patent/EP3555131B1/en
Priority to TW106144224A priority patent/TW201829460A/en
Priority to PCT/EP2017/083051 priority patent/WO2018109174A2/en
Priority to MX2019007020A priority patent/MX2019007020A/en
Priority to US15/843,173 priority patent/US20180186871A1/en
Priority to AU2017378111A priority patent/AU2017378111A1/en
Priority to KR1020197020575A priority patent/KR20190096390A/en
Priority to US16/726,173 priority patent/US11078268B2/en
Ceased legal-status Critical Current

Links

GBGB1621446.2A 2016-12-16 2016-12-16 IL-11 antibodies Ceased GB201621446D0 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
GBGB1621446.2A GB201621446D0 (en) 2016-12-16 2016-12-16 IL-11 antibodies
KR1020197020575A KR20190096390A (en) 2016-12-16 2017-12-15 IL-11 antibody
TW106144224A TW201829460A (en) 2016-12-16 2017-12-15 Il-11 antibodies
BR112019012342A BR112019012342A2 (en) 2016-12-16 2017-12-15 il-11 antibodies
CN201780078160.XA CN110382531B (en) 2016-12-16 2017-12-15 IL-11 antibody
JP2019531960A JP7181870B2 (en) 2016-12-16 2017-12-15 IL-11 antibody
EP17823089.2A EP3555131B1 (en) 2016-12-16 2017-12-15 Il-11 antibodies
CA3045871A CA3045871A1 (en) 2016-12-16 2017-12-15 Il-11 antibodies
PCT/EP2017/083051 WO2018109174A2 (en) 2016-12-16 2017-12-15 Il-11 antibodies
MX2019007020A MX2019007020A (en) 2016-12-16 2017-12-15 Il-11 antibodies.
US15/843,173 US20180186871A1 (en) 2016-12-16 2017-12-15 Il-11 antibodies
AU2017378111A AU2017378111A1 (en) 2016-12-16 2017-12-15 IL-11 antibodies
US16/726,173 US11078268B2 (en) 2016-12-16 2019-12-23 IL-11 antibodies

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1621446.2A GB201621446D0 (en) 2016-12-16 2016-12-16 IL-11 antibodies

Publications (1)

Publication Number Publication Date
GB201621446D0 true GB201621446D0 (en) 2017-02-01

Family

ID=58284622

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1621446.2A Ceased GB201621446D0 (en) 2016-12-16 2016-12-16 IL-11 antibodies

Country Status (1)

Country Link
GB (1) GB201621446D0 (en)

Similar Documents

Publication Publication Date Title
ZA201900373B (en) Anti-tim-3 antibodies
IL259048A (en) Anti-ror1 antibodies
SG10201601719RA (en) Anti-LAG-3 Antibodies
GB201601073D0 (en) Antibodies
IL253633B (en) Anti-transthyretin antibodies
GB201621439D0 (en) IL-11Ra Antibodies
GB201521393D0 (en) Antibodies
GB201521391D0 (en) Antibodies
GB201610044D0 (en) Antibodies
GB201521382D0 (en) Antibodies
PT3250593T (en) Anti-transthyretin antibodies
IL255323A0 (en) Anti-fcrn antibodies
ZA201705662B (en) Anti-transthyretin antibodies
GB201616699D0 (en) Antibodies
ZA201808317B (en) Anti-tnfrsf25 antibodies
GB201603291D0 (en) Antibodies
PT3484921T (en) Anti-il-22r antibodies
GB201509907D0 (en) Antibodies
GB201522394D0 (en) Antibodies
GB201503438D0 (en) Antibodies
IL284022A (en) Anti-transthyretin antibodies
GB201621446D0 (en) IL-11 antibodies
GB201709535D0 (en) IL-11 Antibodies
GB201622197D0 (en) Antibodies
GB201620414D0 (en) Antibodies

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)